Literature DB >> 15096554

Antibody response and viraemia during the course of severe acute respiratory syndrome (SARS)-associated coronavirus infection.

Weijun Chen1, Zuyuan Xu1, Jingsong Mu1, Ling Yang1, Haixue Gan1, Feng Mu1, Baoxing Fan1, Bo He1, Shengyong Huang1, Bo You1, Yongkui Yang1, Xiangjun Tang1, Ling Qiu1, Yan Qiu1, Jie Wen1, Jianqiu Fang1, Jian Wang1.   

Abstract

To understand the time-course of viraemia and antibody responses to severe acute respiratory syndrome-associated coronavirus (SARS-CoV), RT-PCR and ELISA were used to assay 376 blood samples from 135 SARS patients at various stages of the illness, including samples from patients who were in their early convalescent phase. The results showed that IgM antibodies decreased and became undetectable 11 weeks into the recovery phase. IgG antibodies, however, remained detectable for a period beyond 11 weeks and were found in 100 % of patients in the early convalescent phase. SARS-CoV viraemia mainly appeared 1 week after the onset of illness and then decreased over a period of 1 month, becoming undetectable in the blood samples of the convalescent patients. At the peak of viraemia, viral RNA was detectable in 75 % of blood samples from patients who were clinically diagnosed with SARS 1 or 2 weeks before the test.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15096554     DOI: 10.1099/jmm.0.45561-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  27 in total

1.  SARS transmission in Vietnam outside of the health-care setting.

Authors:  P A Tuan; P Horby; P N Dinh; L T Q Mai; M Zambon; J Shah; V Q Huy; S Bloom; R Gopal; J Comer; A Plant
Journal:  Epidemiol Infect       Date:  2006-07-26       Impact factor: 2.451

2.  Data analytics to evaluate the impact of infectious disease on economy: Case study of COVID-19 pandemic.

Authors:  Meleik Hyman; Calvin Mark; Ahmed Imteaj; Hamed Ghiaie; Shabnam Rezapour; Arif M Sadri; M Hadi Amini
Journal:  Patterns (N Y)       Date:  2021-07-27

3.  Dynamic changes of serum SARS-coronavirus IgG, pulmonary function and radiography in patients recovering from SARS after hospital discharge.

Authors:  Lixin Xie; Youning Liu; Baoxing Fan; Yueyong Xiao; Qing Tian; Liangan Chen; Hong Zhao; Weijun Chen
Journal:  Respir Res       Date:  2005-01-08

Review 4.  Severe acute respiratory syndrome (SARS): development of diagnostics and antivirals.

Authors:  Morten Draeby Sørensen; Brian Sørensen; Regina Gonzalez-Dosal; Connie Jenning Melchjorsen; Jens Weibel; Jing Wang; Chen Wie Jun; Yang Huanming; Peter Kristensen
Journal:  Ann N Y Acad Sci       Date:  2006-05       Impact factor: 5.691

5.  Impaired Cytotoxic Response in PBMCs From Patients With COVID-19 Admitted to the ICU: Biomarkers to Predict Disease Severity.

Authors:  Lorena Vigón; Daniel Fuertes; Javier García-Pérez; Montserrat Torres; Sara Rodríguez-Mora; Elena Mateos; Magdalena Corona; Adolfo J Saez-Marín; Rosa Malo; Cristina Navarro; María Aranzazu Murciano-Antón; Miguel Cervero; José Alcamí; Valentín García-Gutiérrez; Vicente Planelles; María Rosa López-Huertas; Mayte Coiras
Journal:  Front Immunol       Date:  2021-05-26       Impact factor: 7.561

6.  Longitudinally profiling neutralizing antibody response to SARS coronavirus with pseudotypes.

Authors:  Nigel J Temperton; Paul K Chan; Graham Simmons; Maria C Zambon; Richard S Tedder; Yasuhiro Takeuchi; Robin A Weiss
Journal:  Emerg Infect Dis       Date:  2005-03       Impact factor: 6.883

7.  SARS-associated coronavirus transmitted from human to pig.

Authors:  Weijun Chen; Minghua Yan; Ling Yang; Boliang Ding; Bo He; Yingzhen Wang; Xiuli Liu; Chenhui Liu; Hui Zhu; Bo You; Shengyong Huang; Jiangguo Zhang; Feng Mu; Zhao Xiang; Xiaoli Feng; Jie Wen; Jianqiu Fang; Jun Yu; Huanming Yang; Jian Wang
Journal:  Emerg Infect Dis       Date:  2005-03       Impact factor: 6.883

8.  The expression and antigenicity of a truncated spike-nucleocapsid fusion protein of severe acute respiratory syndrome-associated coronavirus.

Authors:  Feng Mu; Dongsheng Niu; Jingsong Mu; Bo He; Weiguo Han; Baoxing Fan; Shengyong Huang; Yan Qiu; Bo You; Weijun Chen
Journal:  BMC Microbiol       Date:  2008-11-28       Impact factor: 3.605

Review 9.  A decade after SARS: strategies for controlling emerging coronaviruses.

Authors:  Rachel L Graham; Eric F Donaldson; Ralph S Baric
Journal:  Nat Rev Microbiol       Date:  2013-11-11       Impact factor: 60.633

Review 10.  From SARS to MERS, Thrusting Coronaviruses into the Spotlight.

Authors:  Zhiqi Song; Yanfeng Xu; Linlin Bao; Ling Zhang; Pin Yu; Yajin Qu; Hua Zhu; Wenjie Zhao; Yunlin Han; Chuan Qin
Journal:  Viruses       Date:  2019-01-14       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.